Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A microfluidic platform for sequential ligand labeling and cell binding analysis.

Guodong Sui1, Cheng-Chung Lee, Ken-Ichiro Kamei

  • 1Department of Molecular Medical Pharmacology and Crump Institute for Molecular Imaging, University of California, Los Angeles, 700 Westwood Plaza, Los Angeles, CA 90095, USA.

Biomedical Microdevices
|December 30, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CRISPR-Cas12a2-Based Multiplexed Diagnostic for Rapid and Highly Sensitive Detection of Respiratory Viruses.

Analytical chemistry·2026
Same author

Bioorthogonal Click Chemistry-Enabled Enrichment of Extracellular Vesicles for Integrated Molecular and Functional Liquid Biopsy§.

Accounts of chemical research·2026
Same author

Toward the simultaneous detection of multiple diseases with a highly cost-effective cell-free DNA methylome test.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Noninvasive Assessment of Protease Activity in Osteosarcoma via Click Chemistry-Mediated Enrichment of Extracellular Vesicles.

Advanced functional materials·2026
Same author

Mechanistic insights into HapC: A key enzyme in prodiginine biosynthesis in Hahella chejuensis.

The FEBS journal·2026
Same author

A heavy-chain antibody-drug conjugate targeting glycosylated CEACAM6 inhibits brain metastatic tumor growth.

Cancer letters·2026
Same journal

A pump-free gravity-driven microfluidic chip for rapid RPA-LFS-based detection of Magnaporthe oryzae AvrPi9 gene.

Biomedical microdevices·2026
Same journal

Mechanotherapeutic biomaterials: Overcoming physical barriers to enhance intratumoral drug delivery in solid tumours.

Biomedical microdevices·2026
Same journal

Reversibly-sealable microfluidic platform for multi-molecule gradient delivery to large adherent cell cultures.

Biomedical microdevices·2026
Same journal

3D printed chip as platform to vascularize hiPSCs-derived kidney organoids.

Biomedical microdevices·2026
Same journal

Ingestible smart capsules: from engineering innovation to GI drug delivery.

Biomedical microdevices·2026
Same journal

An inexpensive, portable, refrigeration-free, ready-to-use microfluidic device for real-time multiplexed molecular detection of HIV, HBV, and HCV.

Biomedical microdevices·2026
See all related articles

This study introduces a microfluidic platform for efficient ligand labeling and cell binding analysis. The device saves time and reagents, offering a promising tool for biomedical research and drug discovery.

Area of Science:

  • Biomedical Research
  • Microfluidics
  • Cell Biology

Background:

  • Biochemical and cell biological assays are crucial for screening biomolecules and evaluating pharmacological effects.
  • Traditional methods are often time-consuming and reagent-intensive.

Purpose of the Study:

  • To develop and test an integrated microfluidic platform for miniaturized, semi-automated ligand labeling and cell binding analysis.
  • To reduce time and reagent consumption in biomolecular screening and characterization.

Main Methods:

  • Fabrication of a polydimethylsiloxane (PDMS)-based microfluidic device with a reaction loop and parallel incubation chambers.
  • Fluorophore-labeling of ligands (e.g., epidermal growth factor) and sequential analysis of cell binding to different cell lines.
  • Optical evaluation of ligand-cell interactions.

Related Experiment Videos

Main Results:

  • The microfluidic platform successfully facilitated nanogram-scale ligand labeling and cell binding analysis.
  • Experiments demonstrated significant time and reagent savings compared to traditional methods.
  • The device enabled programmable and semi-automated analysis of ligand-target cell interactions.

Conclusions:

  • The developed microfluidic platform is a highly efficient and promising tool for biomedical research.
  • It offers advantages in speed, reagent conservation, and automation for biomolecular screening and cell-based assays.
  • This technology advances the study of ligand-receptor interactions and pharmacological effects.